Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lipella Pharmaceuticals I...

    NASDAQ: LIPO · Real-Time Price · USD
    2.54
    -0.17 (-6.27%)
    At close: Jun 13, 2025, 3:59 PM
    2.56
    0.79%
    After-hours: Jun 13, 2025, 05:40 PM EDT

    Lipella Pharmaceuticals Statistics

    Share Statistics

    Lipella Pharmaceuticals has 4.47M shares outstanding. The number of shares has increased by -66.49% in one year.

    Shares Outstanding

    n/a
    		 4.47M

    Shares Change (YoY)

    n/a
    		 -66.49%

    Shares Change (QoQ)

    n/a
    		 110.83%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 3.33M

    Failed to Deliver (FTD) Shares

    n/a
    		 5

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 100.09K, so 2.24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 100.09K

    Short % of Shares Out

    n/a
    		 2.24%

    Short % of Float

    n/a
    		 2.35%

    Short Ratio (days to cover)

    n/a
    		 1.89

    Valuation Ratios

    The PE ratio is -0.64 and the forward PE ratio is -0.16. Lipella Pharmaceuticals's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -0.64

    Forward PE

    n/a
    		 -0.16

    PS Ratio

    n/a
    		 5.96

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 1.67

    P/FCF Ratio

    n/a
    		 -0.81

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lipella Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 3.47

    Quick Ratio

    n/a
    		 3.47

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $107,271.4

    Profits Per Employee

    n/a
    		 $-1,003,252.8

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0.2

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -53.31% in the last 52 weeks. The beta is 0.46, so Lipella Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.46

    52-Week Price Change

    n/a
    		 -53.31%

    50-Day Moving Average

    n/a
    		 2.6

    200-Day Moving Average

    n/a
    		 2.93

    Relative Strength Index (RSI)

    n/a
    		 44.88

    Average Volume (20 Days)

    n/a
    		 76,076

    Income Statement

    In the last 12 months, Lipella Pharmaceuticals had revenue of 536.36K and earned -5.02M in profits. Earnings per share was -4.79.

    Revenue

    n/a
    		 536.36K

    Gross Profit

    n/a
    		 -3.08M

    Operating Income

    n/a
    		 -5.08M

    Net Income

    n/a
    		 -5.02M

    EBITDA

    n/a
    		 -5.01M

    EBIT

    n/a
    		 -5.02M

    Earnings Per Share (EPS)

    n/a
    		 -4.79
    Full Income Statement

    Balance Sheet

    The company has 2.18M in cash and 47.6K in debt, giving a net cash position of 2.14M.

    Cash & Cash Equivalents

    n/a
    		 2.18M

    Total Debt

    n/a
    		 47.6K

    Net Cash

    n/a
    		 2.14M

    Retained Earnings

    n/a
    		 -15.34M

    Total Assets

    n/a
    		 4.86B

    Working Capital

    n/a
    		 4.05B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.95M and capital expenditures 0, giving a free cash flow of -3.95M.

    Operating Cash Flow

    n/a
    		 -3.95M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -3.95M

    FCF Per Share

    n/a
    		 -3.77
    Full Cash Flow Statement

    Margins

    Gross margin is -573.65%, with operating and profit margins of -947.23% and -935.25%.

    Gross Margin

    n/a
    		 -573.65%

    Operating Margin

    n/a
    		 -947.23%

    Pretax Margin

    n/a
    		 -935.25%

    Profit Margin

    n/a
    		 -935.25%

    EBITDA Margin

    n/a
    		 -934.71%

    EBIT Margin

    n/a
    		 -947.23%

    FCF Margin

    n/a
    		 -736.59%

    Dividends & Yields

    LIPO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LIPO is $16, which is 529.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 529.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 8, 2024. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Nov 8, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -4.65

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist